![D. Kirkpatrick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
D. Kirkpatrick
Vorstandsvorsitzender bei
ENSYSCE BIOSCIENCES, INC.
Vermögen: 27 $ am 31.07.2026
Profil
D.
Lynn Kirkpatrick was the founder of ProlX Pharmaceuticals Corp., founded in 1999, serving as President & Chief Executive Officer from 1999 to 2006.
Dr. Kirkpatrick is the founder of Phusis Therapeutics, Inc., founded in 2009.
The current job is Chief Executive Officer & Director at Ensysce Biosciences, Inc., starting in 2026.
Former jobs include President, Chief Executive Officer & Director at Ensysce Biosciences, Inc.; Director at BiologicsMD, Inc.; Chief Scientific Officer at Biomira, Inc.; Professor at the University of Regina from 1983 to 2001; and Chief Scientific Officer at Cascadian Therapeutics LLC from 2006 to 2008.
Education includes undergraduate and doctorate degrees from the University of Saskatchewan.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 13.11.2025 | 107 ( 0 % ) | 27 $ | 31.07.2026 |
Aktive Positionen von D. Kirkpatrick
| Unternehmen | Position | Beginn |
|---|---|---|
| ENSYSCE BIOSCIENCES, INC. | Vorstandsvorsitzender | 01.01.2009 |
Ehemalige bekannte Positionen von D. Kirkpatrick
| Unternehmen | Position | Ende |
|---|---|---|
| CASCADIAN THERAPEUTICS INC (USA) | Technik-/Wissenschafts-/F&E-Leiter | 31.12.2008 |
Biomira, Inc.
 Biomira, Inc. Medical/Nursing ServicesHealth Services Develops and researches products to monitor and treat cancer | Technik-/Wissenschafts-/F&E-Leiter | 11.12.2007 |
ProlX Pharmaceuticals Corp.
 ProlX Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals products | Vorstandsvorsitzender | 01.01.2006 |
University of Regina
 University of Regina Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.2001 |
Phusis Therapeutics, Inc.
 Phusis Therapeutics, Inc. BiotechnologyHealth Technology Develops novel targeted small molecule therapeutics | Gründer | - |
Ausbildung von D. Kirkpatrick
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
74
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Develops and researches products to monitor and treat cancer | Health Services |
University of Regina
University of Regina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Develops therapeutic products for the treatment of cancer | Health Technology |
BiologicsMD, Inc.
 BiologicsMD, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical therapeutic development company which focuses on smart therapies for hair loss and bone disorders | Health Technology |
University of Saskatchewan
 University of Saskatchewan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ProlX Pharmaceuticals Corp.
ProlX Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals products | Health Technology |
Ensysce Biosciences, Inc. /Old/
 Ensysce Biosciences, Inc. /Old/ Medical DistributorsDistribution Services Supplies drugs for pain and cancer markets | Distribution Services |
Phusis Therapeutics, Inc.
Phusis Therapeutics, Inc. BiotechnologyHealth Technology Develops novel targeted small molecule therapeutics | Health Technology |
Ensysce Biosciences, Inc.
 Ensysce Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
